This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 159 
1 out of 10 Years Active: 2026
Title: Langyong Mao: Innovator in Pharmaceutical Development
Introduction
Langyong Mao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug conjugates. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Langyong Mao holds a patent for an "ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF." This invention represents a novel approach to targeted therapy, showcasing his expertise in antibody-drug conjugates.
Career Highlights
Throughout his career, Langyong has worked with notable companies such as Shanghai Hengrui Pharmaceutical and Jiangsu Hengrui Medicine Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Langyong has collaborated with talented individuals, including Hua Ying and Sijia Wang. These partnerships have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.
Conclusion
Langyong Mao is a distinguished inventor whose work in pharmaceuticals continues to pave the way for advancements in cancer treatment. His dedication to innovation and collaboration highlights the importance of teamwork in achieving significant breakthroughs in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile